Latest Regulatory Milestones News

Bayan Mining and Minerals Limited has verified key rare earth element minerals at its Desert Star project in California, confirming a phosphate-rich hard-rock system dominated by light rare earth elements. The company is advancing towards its maiden drill program following regulatory approvals.

Condor Energy has agreed to acquire Jaguar Exploration’s 20% stake in the TEA 86 offshore Peru project, moving to full ownership. The deal, structured through performance shares, aims to simplify equity and support licence conversion and future partnerships.

Mesoblast Limited (ASX:MSB, Nasdaq:MESO) has received FDA Investigational New Drug clearance to initiate a pivotal clinical trial of its cell therapy Ryoncil in children with Duchenne Muscular Dystrophy, aiming to address inflammation-driven disease progression.

Insignia Financial has received Foreign Investment Review Board approval for its proposed acquisition by Daintree BidCo, clearing a key regulatory hurdle. The scheme now awaits shareholder and court approvals, with the board recommending shareholder support.

Aguia Resources’ Brazilian subsidiary has achieved a key regulatory milestone with official fertiliser registration, enabling commercial sales of its PAMPAFOS phosphate product in Brazil’s large agricultural market.

Imricor Medical Systems has submitted its NorthStar Mapping System for FDA pediatric label expansion, aiming to accelerate adoption in over 250 US children’s hospitals and broaden its commercial footprint.

Vitrafy Life Sciences has announced the completion of Phase II testing of a platelet cryopreservation study with the U.S. Army Institute of Surgical Research, showing consistent results for the legacy wash-based protocol and encouraging outcomes for an innovative no-wash approach.

National Storage REIT (ASX:NSR) has confirmed satisfaction of key foreign investment conditions for its proposed acquisition by a Brookfield-GIC consortium, with securityholder meetings scheduled for mid-April.

Energy Transition Minerals Ltd (ASX:ETM) has obtained Foreign Direct Investment approval from the Spanish Government, a key regulatory milestone enabling the completion of its acquisition of the Penouta Tin-Tantalum Mine in Spain. The company anticipates finalising the acquisition this quarter, pending mining licence transfers.

Algorae Pharmaceuticals has reached a key regulatory milestone as the TGA accepts its initial registration dossier, paving the way for potential commercialisation of its generic medicines in Australia and New Zealand.

NH3 Clean Energy has entered a pivotal phase in its WAH2 Project development, partnering with global engineering giant Linde and progressing funding discussions to secure up to A$567 million. This collaboration aims to reduce capital and operational risks as the project moves closer to a final investment decision.

Everest Metals Corporation has reported promising metallurgical test results for its Mt Edon Critical Mineral Project, alongside submitting a key Mining Proposal to regulators, signalling progress toward commercial development.